BF Biosciences Limited (PSX:BFBIO)
131.13
-7.73 (-5.57%)
At close: Mar 9, 2026
-23.79% (1Y)
| Market Cap | 11.58B |
| Revenue (ttm) | 8.22B |
| Net Income (ttm) | 598.64M |
| Shares Out | 88.33M |
| EPS (ttm) | 6.78 |
| PE Ratio | 19.34 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 323,859 |
| Average Volume | 417,841 |
| Open | 134.99 |
| Previous Close | 138.86 |
| Day's Range | 124.97 - 135.11 |
| 52-Week Range | 117.00 - 194.90 |
| Beta | n/a |
| RSI | 30.58 |
| Earnings Date | Feb 25, 2026 |